| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Ludwig Institute for Cancer Research, 9 Earl Street, Toronto, Ontario M4Y 1M4, Canada
Aberrant crypt foci can be identified in the colons of rodents treated 3 wk earlier with azoxymethane, a known colon carcinogen. These crypts can easily be visualized in the unsectioned methylene blue-stained colons under light microscopy, where they are distinguished by their increased size, more prominent epithelial cells, and pericryptal space. They occur as single aberrant crypts or as two, three, or four aberrant crypts in a cluster. We compared the reported ability of carcinogens associated with the human diet to induce colon cancer with the measured rate of induction of aberrant crypts in female CF1 mice and Sprague-Dawley rats. The carcinogens used were 1,2-dimethylhydrazine, methyl nitrosourea, N-nitrosodimethylamine, benzo(a)pyrene, aflatoxin B1, 2-amino-6-methyl-dipyrido[1,2-
:3',2'-d]imidazole, 2-amino-3-methylimidazo[4,5-P]quinoline, 2-amino-3,4-dimethylimidazo[4,5-P]quinoline, and 3-amino-1-methyl-5H-pyrido[4,3-b]indole. Graded doses of these compounds were given to the animals by gavage twice with a 4-day interval, and the animals were terminated 3 wk later. All colon carcinogens induced aberrant crypts in a dose-related fashion. N-Nitrosodimethylamine and 3-amino-1-methyl-5H-pyrido[4,3-b]indole, carcinogenic compounds that do not induce colon cancer, did not induce them. The ability of the studied compounds to induce aberrant crypts was species specific; e.g., aflatoxin B1 and 2-amino-3,4-dimethylimidazo[4,5-P]quinoline induce about 20 times more in rats than mice. This relationship was consistent with their reported ability to induce colon cancer in these species. Results of the present study support the use of the aberrant crypt assays to screen colon-specific carcinogens and to study the process of colon carcinogenesis.
1 Present address: Department of Biochemistry, Warsaw Medical Academy, Banacha 1, 02-097 Warsaw, Poland.
2 Present address: Department of Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba R3T 2N2, Canada.
3 To whom requests for reprints should be addressed.
Received 8/11/88. Revised 11/28/88. Accepted 12/ 5/88.
This article has been cited by other articles:
![]() |
Y. Feng, J. R. Neale, M. A. Doll, and D. W. Hein Chemoprevention of Arylamine-Induced Colorectal Aberrant Crypts Experimental Biology and Medicine, January 1, 2008; 233(1): 71 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohkawara, H. Furuya, K. Nagashima, N. Asanuma, and T. Hino Oral Administration of Butyrivibrio fibrisolvens, a Butyrate-Producing Bacterium, Decreases the Formation of Aberrant Crypt Foci in the Colon and Rectum of Mice J. Nutr., December 1, 2005; 135(12): 2878 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Zamuner, A. W. Bak, P. R. Devchand, and J. L. Wallace Predisposition to Colorectal Cancer in Rats with Resolved Colitis: Role of Cyclooxygenase-2-Derived Prostaglandin D2 Am. J. Pathol., November 1, 2005; 167(5): 1293 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fukushima, H. Wanibuchi, K. Morimura, S. Iwai, D. Nakae, H. Kishida, H. Tsuda, N. Uehara, K. Imaida, T. Shirai, et al. Existence of a Threshold for Induction of Aberrant Crypt Foci in the Rat Colon with Low Doses of 2-Amino-1-methyl-6-phenolimidazo[4,5-b]pyridine Toxicol. Sci., July 1, 2004; 80(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Raju and R. P. Bird Energy Restriction Reduces the Number of Advanced Aberrant Crypt Foci and Attenuates the Expression of Colonic Transforming Growth Factor {beta} and Cyclooxygenase Isoforms in Zucker Obese (fa/fa) Rats Cancer Res., October 15, 2003; 63(20): 6595 - 6601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kassie, S. Rabot, M. Uhl, W. Huber, H. M. Qin, C. Helma, R. Schulte-Hermann, and S. Knasmuller Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions Carcinogenesis, July 1, 2002; 23(7): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Buddington, J. B. Donahoo, and R. K. Buddington Dietary Oligofructose and Inulin Protect Mice from Enteric and Systemic Pathogens and Tumor Inducers J. Nutr., March 1, 2002; 132(3): 472 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts Cancer Res., December 1, 2001; 61(24): 8689 - 8696. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Andreassen, R. Vikse, I.-L. Steffensen, J. E. Paulsen, and J. Alexander Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele Mutagenesis, July 1, 2001; 16(4): 309 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardelli, D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer Carcinogen-specific induction of genetic instability PNAS, April 5, 2001; (2001) 81082898. [Abstract] [Full Text] |
||||
![]() |
S. Fukushima, N. Takada, T. Hori, W. Min, H. Wanibuchi, and S. Yamamoto Suppression of Chemical Carcinogenesis by Water-Soluble Organosulfur Compounds J. Nutr., March 1, 2001; 131(3): 1049S - 1053. [Abstract] [Full Text] |
||||
![]() |
M. Pedroni, E. Sala, A. Scarselli, F. Borghi, M. Menigatti, P. Benatti, A. Percesepe, G. Rossi, M. Foroni, L. Losi, et al. Microsatellite Instability and Mismatch-Repair Protein Expression in Hereditary and Sporadic Colorectal Carcinogenesis Cancer Res., February 1, 2001; 61(3): 896 - 899. [Abstract] [Full Text] |
||||
![]() |
P Perrin, F Pierre, Y Patry, M Champ, M Berreur, G Pradal, F Bornet, K Meflah, and J Menanteau Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats Gut, January 1, 2001; 48(1): 53 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Fenoglio-Preiser and A. Noffsinger Review Article: Aberrant Crypt Foci: A Review Toxicol Pathol, November 1, 1999; 27(6): 632 - 642. [PDF] |
||||
![]() |
A. P. Soler, R.D. Miller, K. V. Laughlin, N. Z. Carp, D. M. Klurfeld, and J. M. Mullin Increased tight junctional permeability is associated with the development of colon cancer Carcinogenesis, August 1, 1999; 20(8): 1425 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Paulsen, I.-L. Steffensen, A. Andreassen, R. Vikse, and J. Alexander Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice Carcinogenesis, July 1, 1999; 20(7): 1277 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardelli, D. P. Cahill, G. Lederer, M. R. Speicher, K. W. Kinzler, B. Vogelstein, and C. Lengauer From the Cover: Carcinogen-specific induction of genetic instability PNAS, May 8, 2001; 98(10): 5770 - 5775. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |